Skip to main content
Frontiers in Oncology logoLink to Frontiers in Oncology
. 2022 Dec 13;12:1106553. doi: 10.3389/fonc.2022.1106553

Corrigendum: Heparin binding epidermal growth factor–like growth factor is a prognostic marker correlated with levels of macrophages infiltrated in lung adenocarcinoma

Nguyen Van Hiep 1,2,3, Wei-Lun Sun 4,5,6, Po-Hao Feng 4,5,6, Cheng-Wei Lin 1,6,7, Kuan-Yuan Chen 4,5,6,8, Ching-Shan Luo 1,4,6, Le Ngoc Dung 3, Hoang Van Quyet 3, Sheng-Ming Wu 4,5,6,*, Kang-Yun Lee 1,4,5,6,8,*
PMCID: PMC9793069  PMID: 36582792

In the published article, there was an error in affiliation 1. Instead of “IInternational Ph.D. Program in Medicine, College of Medicine, Taipei Medical University, Taipei, Taiwan”, it should be “International Ph.D. Program in Medicine, College of Medicine, Taipei Medical University, Taipei, Taiwan”.

In the published article, there was an error in the Ethics statement. The IRB number was incorrectly displayed as “IRB no. N20210313”. The correct IRB number is “IRB no. N202103013”. The correct Ethics statement appears below.

Ethics statement

The study protocol was approved by the Joint Institutional Review Board of Taipei Medical University (IRB no. N202103013). The patients/participants provided their written informed consent to participate in this study.

The authors apologize for these errors and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.

Publisher’s note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.


Articles from Frontiers in Oncology are provided here courtesy of Frontiers Media SA

RESOURCES